Navigation Links
Skin Patch Offers Relief to Patients with Parkinson's disease

Schwarz Pharma has come up with a new neupro skin patch which is offered the licence to be marketed in UK. It is said to offer relief to patients// in the early stages of Parkinson's disease. It delivers a drug that mimics the effects of a naturally occurring brain chemical, which is in short supply in people with Parkinson's.

The Parkinson's Disease Society said that the patch would aid the patients to manage their symptoms more easily. Statistics show that about 8,000 to10,000 new cases of Parkinson's are diagnosed in the UK every year. About 95% of these cases are usually aged over 40 years.

In Parkinson’s disease patients have a shortage of the brain chemical dopamine. This controls connections between nerve cells, leading to symptoms such as tremors. The main treatment included a drug which the patient consumes called the dopamine agonist. This acts directly on the dopamine receptors in the brain.

But now this latest technique contains a new dopamine agonist, called rotigotine, and delivers a continuous dose of the drug over 24 hours, so patients only having to change the patch once a day. Robert Meadowcroft, director of policy, campaigns and information at the Parkinson's Disease Society, said that his patch is very useful than the previous treatments and is also safe and effective in early stage of Parkinson's disease.

Dr Ray Chaudhuri, a consultant neurologist at University Hospital Lewisham, in south London, said that it is a new and simple way of delivering a dopamine agonist which helps to overcome the problems associated with oral administration.
'"/>




Page: 1

Related medicine news :

1. FDA Approves Birth Control Skin Patch
2. Estrogen Patch is Safer than Pills for Heart
3. Painkilling Patch As Effective As Intravenous Delivery Systems
4. Fentanyl Narcotic Pain Patch under Scrutiny
5. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
6. FDA Warns Against Birth-Control Patch
7. Nicotine Patches help to quit smoking
8. Reliable Help For Smokers From Nicotine Patches and Former Smokers
9. Increased Risk of Clot with Birth-Control Patch
10. Eye Patches Could Delay Healing In Corneal Abrasions
11. Contraceptive Patch Carries Risk of Blood clots
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... ... February 23, 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, ... a raffle. Throughout the month of February, patients who visit Hamlin Dental Group will ... a dinner for two at the Cheesecake Factory. , Tickets are available for ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Dr. David Mahon ... Henderson, NV 89052. Dr. Mahon was named a 2017 Top Patient Rated Henderson ... is an online directory that recognizes local physicians and dentists who have earned high ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... the pre-eminent publication and community for those in the fight against cancer, has ... important in their success. HRA will release top-line findings in a webinar, ...
(Date:2/23/2017)... Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... her Smiling Patriot program today with a new Indiegogo campaign . ... care to homeless veterans in the Los Angeles area, either as a participating patient ...
(Date:2/23/2017)... ... February 23, 2017 , ... Carlos Gutierrez has lived his ... to spiritually evolve, which is the purpose of everyone in this universe. As Gutierrez ... (published by Balboa Press) attempts to guide readers to expand one’s spiritual life. , ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017  This ... US$ Thousand by the following Products: ... analyzed in the report include Pharmaceuticals, and Agrochemicals. The ... Japan , Europe , ... provided for the period 2015 through 2022. Also, a ...
(Date:2/24/2017)...  The particle counters market is projected to ... 275.9 million in 2016, at a CAGR of ... http://www.reportlinker.com/p04718602-summary/view-report.html The growing pharmaceutical and ... growth in manufacturing industries in emerging nations are ... counters. On the other hand, technical limitations of ...
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
Breaking Medicine Technology: